Home › Funds › Affinity Asset Advisors, LLC › APGE

Affinity Asset Advisors, LLC position in APGE

APOGEE THERAPEUTICS INC

Affinity Asset Advisors, LLC reported holding 987,000 shares of APGE (APOGEE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$131.0M, representing 6.30% of its reported portfolio and ranking #2 among its reported holdings. Affinity Asset Advisors, LLC has disclosed APGE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)987.00K sh
Reported value held$131.00M
Portfolio Weight6.30%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Affinity Asset Advisors, LLC's APGE position evolved

Affinity Asset Advisors, LLC first disclosed a stake in APGE in Q3 2023 at 1,045,110 shares (US$22.3M). The position peaked in Q2 2026 at 987,000 shares, worth US$131.0M. Across 12 filings, Affinity Asset Advisors, LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 987,000 shares valued at US$131.0M — a reduction of -297,926 shares quarter over quarter.. Notable position changes include a 49% trim in Q4 2023, a 100% trim in Q2 2025, a 46837% increase in Q3 2025.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.05M $22.26M New
Q4 2023 537.09K $15.01M Reduce
Q1 2024 592.09K $39.34M Add
Q2 2024 836.28K $32.91M Add
Q3 2024 664.20K $39.01M Reduce
Q4 2024 931.73K $42.21M Add
Q1 2025 1.15M $43.01M Add
Q2 2025 2.50K $108.58K Reduce
Q3 2025 1.17M $46.62M Add
Q4 2025 1.23M $93.21M Add
Q1 2026 1.28M $108.15M Add
Q2 2026 987.00K $131.00M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About APGE and 13F data

APGE (APOGEE THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 59 other funds we track also report a position in APGE — the largest reported positions include Venrock Adviser, LLC (US$1.13B), HBK INVESTMENTS L P (US$378.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$231.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding APGE

All APGE fund holders →

FAQ

How long has Affinity Asset Advisors, LLC held APGE?

Affinity Asset Advisors, LLC has disclosed APGE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Affinity Asset Advisors, LLC's current position in APGE?

As of Q2 2026, Affinity Asset Advisors, LLC holds 987.00K shares of APGE (APOGEE THERAPEUTICS INC), valued at $131.00M, representing 6.30% of its reported portfolio and ranking #2.

Has Affinity Asset Advisors, LLC been buying or selling APGE?

In the latest 13F filing (Q2 2026), Affinity Asset Advisors, LLC reduced its position in APGE. The position peaked in Q2 2026 at 987.00K shares.

Which other funds hold APGE?

Other major institutional holders of APGE include Venrock Adviser, LLC, HBK INVESTMENTS L P, DRIEHAUS CAPITAL MANAGEMENT LLC, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.